[1] GBD 2015 Mortality and Causes of Death Collaborators.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1459-1544.   doi: 10.1016/S0140-6736(16)31012-1
[2] Schwartz CJ, Valente AJ, Kelley JL, et al.  Thrombosis and the development of atherosclerosis: rokitansky revisited[J]. Semin Thromb Hemost, 1988, 14(2): 189-195.   doi: 10.1055/s-2007-1002775
[3] Kunadian V, Chieffo A, Camici PG, et al.  An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group[J]. Eur Heart J, 2020, 41(37): 3504-3520.   doi: 10.1093/eurheartj/ehaa503
[4] Del Buono MG, Montone RA, Camilli M, et al.  Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 78(13): 1352-1371.   doi: 10.1016/j.jacc.2021.07.042
[5] Hansen B, Holtzman JN, Juszczynski C, et al.  Ischemia with no obstructive arteries (INOCA): a review of the prevalence, diagnosis and management[J]. Curr Probl Cardiol, 2023, 48(1): 101420-.   doi: 10.1016/j.cpcardiol.2022.101420
[6] Lyon AR, Citro R, Schneider B, et al.  Pathophysiology of takotsubo syndrome: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 77(7): 902-921.   doi: 10.1016/j.jacc.2020.10.060
[7] Deussen A, Ohanyan V, Jannasch A, et al.  Mechanisms of metabolic coronary flow regulation[J]. J Mol Cell Cardiol, 2012, 52(4): 794-801.   doi: 10.1016/j.yjmcc.2011.10.001
[8] Guo R, Weingärtner S, Šiurytė P, et al.  Emerging techniques in cardiac magnetic resonance imaging[J]. J Magn Reson Imaging, 2022, 55(4): 1043-1059.   doi: 10.1002/jmri.27848
[9]

Rush CJ, Berry C, Oldroyd KG, et al. Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction[J/OL]. JAMA Cardiol, 2021, 6(10): 1130−1143[2023-07-06].https://jamanetwork.com/journals/jamacardiology/fullarticle/2781078. DOI: 10.1001/jamacardio.2021.1825.
[10] Sharir T, Slomka PJ, Berman DS.  Solid-state SPECT technology: fast and furious[J]. J Nucl Cardiol, 2010, 17(5): 890-896.   doi: 10.1007/s12350-010-9284-5
[11] Wells RG, Timmins R, Klein R, et al.  Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model[J]. J Nucl Med, 2014, 55(10): 1685-1691.   doi: 10.2967/jnumed.114.139782
[12] Hsu B, Hu LH, Yang BH, et al.  SPECT myocardial blood flow quantitation toward clinical use: a comparative study with 13N-Ammonia PET myocardial blood flow quantitation[J]. Eur J Nucl Med Mol Imaging, 2017, 44(1): 117-128.   doi: 10.1007/s00259-016-3491-5
[13] Liu L, Abdu FA, Yin GQ, et al.  Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA)[J]. J Nucl Cardiol, 2021, 28(6): 3025-3037.   doi: 10.1007/s12350-020-02252-8
[14] Li LL, Pang ZK, Wang J, et al.  Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA[J]. J Nucl Cardiol, 2023, 30(6): 2578-2592.   doi: 10.1007/s12350-023-03332-1
[15] Zhang H, Caobelli F, Che WL, et al.  The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study[J]. Eur J Nucl Med Mol Imaging, 2023, 50(7): 1940-1953.   doi: 10.1007/s00259-023-06125-3
[16] Wang J, Li S, Chen WQ, et al.  Diagnostic efficiency of quantification of myocardial blood flow and coronary flow reserve with CZT dynamic SPECT imaging for patients with suspected coronary artery disease: a comparative study with traditional semi-quantitative evaluation[J]. Cardiovasc Diagn Ther, 2021, 11(1): 56-67.   doi: 10.21037/cdt-20-728
[17] Cerqueira MD, Weissman NJ, Dilsizian V, et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J]. Circulation, 2002, 105(4): 539-542.   doi: 10.1161/hc0402.102975
[18] Bourque JM.  ISCHEMIA sheds light on INOCA: understanding population heterogeneity to inform prognosis and guide management[J]. JACC Cardiovasc Imaging, 2023, 16(1): 75-77.   doi: 10.1016/j.jcmg.2022.10.012
[19] Mohammed AA, Zhang HB, Abdu FA, et al.  Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA[J]. Clin Cardiol, 2023, 46(2): 204-213.   doi: 10.1002/clc.23962
[20] Iskander S, Iskandrian AE.  Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging[J]. J Am Coll Cardiol, 1998, 32(1): 57-62.   doi: 10.1016/s0735-1097(98)00177-6
[21] Cho SG, Kim J, Song HC.  Debates over NICE guideline update: what are the roles of nuclear cardiology in the initial evaluation of stable chest pain?[J]. Nucl Med Mol Imaging, 2019, 53(5): 301-312.   doi: 10.1007/s13139-019-00607-9
[22] Ziadi MC.  Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis[J]. Cardiovasc Diagn Ther, 2017, 7(2): 206-218.   doi: 10.21037/cdt.2017.04.10
[23] Pang ZK, Wang J, Li S, et al.  Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease[J]. Int J Cardiovasc Imaging, 2021, 37(1): 367-378.   doi: 10.1007/s10554-020-01962-x
[24] Panjer M, Dobrolinska M, Wagenaar NRL, et al.  Diagnostic accuracy of dynamic CZT-SPECT in coronary artery disease. A systematic review and meta-analysis[J]. J Nucl Cardiol, 2022, 29(4): 1686-1697.   doi: 10.1007/s12350-021-02721-8